https://doi.org/10.29046/TMF.010.1.005">
  •  
  •  
 

Abstract

Introduction

Cryptococcal meningitis is an infectious complication of immunecompromised states that carries a high rate of mortality orrelapse. Although Infectious Disease Society of America (IDSA)guidelines outline the recommended treatment regimen forcryptococcal meningitis, clinicians take a heterogenous clinicalapproach. This study examines the use of antifungal regimens intreating cryptococcal meningitis at a tertiary care hospital.

Share

COinS
https://doi.org/10.29046/TMF.010.1.005">